How many insider declarations has Gunn Neil filed?

Gunn Neil has filed 3 public insider declarations with SEC (Form 4).

What is Gunn Neil's role?

Gunn Neil's reported role is not specified by the regulator across the filings.

Which companies does Gunn Neil report trades for?

Gunn Neil reports trades for Neogenomics INC.

What is Gunn Neil's declared buy vs sell volume?

Across the available history, declared buys total 31k€ and disposals 0.

← Executives ★ Sign in to follow

GN

Gunn Neil

OFFICER

·SEC (Form 4)

Neogenomics INC

0

申报总数

0

公司

€30,917

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

T+90 胜率

100%

T+90 平均收益

+20.6%

基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

无可用的信号评分。

Discover the detailed record of transactions filed by Gunn Neil. Director active across 1 company, notably Neogenomics INC. Aggregated, 3 reports have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €31k. Activity tracked since 10 August 2024. The latest transaction was disclosed on 1 June 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is free.

Companies and markets linked to Gunn Neil

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Neogenomics INC (US)

申报3 总计

◇

Gunn Neil

Director高管2025年6月1日Neogenomics INC

0SEC ↗

12,254 股0Common StockSEC:0001077183-25-000124:0

▲

Gunn Neil

Director高管2025年5月5日Neogenomics INC

US$34,97741SEC ↗

4,510.31 股@ US$7.755100.0% 占其流量Common StockSEC:0001077183-25-000093:0

标准退出：2025年8月3日 (T+90)

◇

Gunn Neil

Director高管2024年8月10日Neogenomics INC

0SEC ↗

11,336 股0Common StockSEC:0001077183-24-000124:0

3 条申报中的 3 条

InsidersTradesSigma

← Executives ★ Sign in to follow

GN

Gunn Neil

OFFICER

·SEC (Form 4)

Neogenomics INC

0

申报总数

0

公司

€30,917

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

T+90 胜率

100%

T+90 平均收益

+20.6%

基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

无可用的信号评分。

Discover the detailed record of transactions filed by Gunn Neil. Director active across 1 company, notably Neogenomics INC. Aggregated, 3 reports have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €31k. Activity tracked since 10 August 2024. The latest transaction was disclosed on 1 June 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is free.